Steatosis News and Research

RSS
Researchers forecast obesity-related conditions to rise among children

Researchers forecast obesity-related conditions to rise among children

Researcher receives grant to study how changes in gut bacteria could lead to obesity-related disorders

Researcher receives grant to study how changes in gut bacteria could lead to obesity-related disorders

Sleep-disordered breathing promotes progression of pediatric NAFLD to NASH

Sleep-disordered breathing promotes progression of pediatric NAFLD to NASH

New diagnostic model may become cheaper and easier alternative to screen for NAFLD

New diagnostic model may become cheaper and easier alternative to screen for NAFLD

CNIO study shows proinflammatory molecule IL-17A can be key factor in development of NASH and HCC

CNIO study shows proinflammatory molecule IL-17A can be key factor in development of NASH and HCC

Targeted molecular therapy reduces initial development of NAFLD in mice

Targeted molecular therapy reduces initial development of NAFLD in mice

Researchers develop in vitro model system for investigating etiology of NAFLD

Researchers develop in vitro model system for investigating etiology of NAFLD

Pioglitazone effective in diabetes patients with NASH

Pioglitazone effective in diabetes patients with NASH

NR supplements can reduce diabetes-related complications in mice

NR supplements can reduce diabetes-related complications in mice

Daily dose of coffee could help reverse non-alcoholic fatty liver disease

Daily dose of coffee could help reverse non-alcoholic fatty liver disease

Newcastle scientists develop new type of genetic blood test to diagnose liver scarring

Newcastle scientists develop new type of genetic blood test to diagnose liver scarring

Researchers find prevalence of steatosis in liver transplant recipients

Researchers find prevalence of steatosis in liver transplant recipients

Absence of PEMT enzyme leads to development of fatty liver disease and tumours in thin patients

Absence of PEMT enzyme leads to development of fatty liver disease and tumours in thin patients

Potential treatment target identified for fatty liver disease

Potential treatment target identified for fatty liver disease

Viking submits IND application to FDA to conduct VK2809 Phase 2 study in patients with LDL-C and fatty liver disease

Viking submits IND application to FDA to conduct VK2809 Phase 2 study in patients with LDL-C and fatty liver disease

Georgia State University researcher receives $1.35 million federal grant to study effects of emulsifiers

Georgia State University researcher receives $1.35 million federal grant to study effects of emulsifiers

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

NuSI launches groundbreaking clinical study to halt nonalcoholic fatty liver disease in children

NuSI launches groundbreaking clinical study to halt nonalcoholic fatty liver disease in children

Study shows NASH linked to 50% higher death rates compared with NAFLD

Study shows NASH linked to 50% higher death rates compared with NAFLD

Remogliflozin etabonate: A potential treatment option for management of NASH and NAFLD

Remogliflozin etabonate: A potential treatment option for management of NASH and NAFLD